XML 72 R62.htm IDEA: XBRL DOCUMENT v3.23.1
Noncontrolling Interest (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended
Mar. 07, 2023
Nov. 30, 2022
Mar. 31, 2023
Dec. 31, 2022
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]        
Common stock shares outstanding     100,596,406 94,510,537
Veris Health Inc [Member] | Unrelated Third Parties [Member]        
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]        
Investment ownership percentage     19.56%  
Veris Health Inc [Member] | Parent Company [Member]        
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]        
Investment ownership percentage     80.44%  
Series A Preferred Stock [Member]        
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]        
Sale of stock, transaction value $ 13,625,000      
Series A Convertible Preferred Stock [Member]        
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]        
Number of shares available for issue 13,625      
Issuance of shares value $ 1,000      
Preferred shares conversion price $ 1.394      
Dividend percentage 20.00%      
Lucid Diagnostics Inc [Member]        
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]        
Common stock shares outstanding     41,753,603  
Partners capital account units acquisitions     31,302,420  
Sale of stock, transaction value     $ 300,000  
Sale of stock, sold     230,068  
Sale of stock, commission percenatge     3.00%  
Lucid Diagnostics Inc [Member] | Maximum [Member]        
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]        
Sale of stock, transaction value   $ 6,500,000    
Veris Health Inc [Member]        
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]        
Common stock shares outstanding     8,000,000